Scientific Publications

August 5 2018

Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment

September 23 2017

Role of STAT3 in Skin Fibrosis and Transforming Growth Factor Beta Signalling

May 22 2017

Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice

August 1 2016

STAT3 Inhibitors in Cancer: A Comprehensive Update

August 1 2016

STAT-3 contributes to Pulmonary Fibrosis through Epithelial Injury and Fibroblast-Myofibroblast

July 1 2016

Diminution of Signal Transducer and Activator of Transcription 3 Signaling inhibits Vascular Permeability and Anaphylaxis

June 23 2016

STAT3 Inhibition Prevents Lung Inflammation, Remodeling, and Accumulation of Th2 and Th17 Cells in a Murine Asthma Model

May 3 2016

Small-molecule Inhibition of STAT3 in Radioresistant Head and Neck Squamous Cell Carcinoma

November 30 2015

Small-molecule targeting of Signal Transducer and Activator of Transcription (STAT) 3 to treat Non-Small Cell Lung Cancer

April 24 2015

Inhibition of STAT3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia